SCM
CTSO icon

Segantii Capital Management’s Cytosorbents Corp CTSO Stock Holding History

Segantii Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-27,200
Closed -$122K – 105
2017
Q1 		$122K Buy
27,200
+23,100
+563% +$129K 0.02% 190
2016
Q4 		$23K Buy
+4,100
New +$22.4K 0.01% 121

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Segantii Capital Management's CTSO Position: Q2 2017 in Review

Segantii Capital Management sold out of Cytosorbents Corp (CTSO) in Q2 2017, closing a stake of 27,200 shares — an estimated $122K sold.

Segantii Capital Management first reported a position in CTSO in Q4 2016 and held it in 2 quarters. The position peaked at $122K in Q1 2017. 32 funds tracked by Wall St. Rank hold CTSO as of Q2 2017.

  • Segantii Capital Management reported no remaining Cytosorbents Corp position as of Q2 2017 after selling out during the quarter.
  • Segantii Capital Management sold 27,200 Cytosorbents Corp shares in Q2 2017, an estimated $122K.
  • Segantii Capital Management first reported a position in Cytosorbents Corp in Q4 2016 and held it in 2 quarters.
  • Segantii Capital Management's Cytosorbents Corp position peaked at $122K in Q1 2017.
  • 32 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2017.

Based on Segantii Capital Management's 13F filing for Q2 2017, filed 2 Aug 2017.